| Trial registration number
|
NCT04941131 |
Full text link
Last imported at : June 30, 2021, 2:30 a.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT04941131
|
First author
Last imported at : June 30, 2021, 2:30 a.m.
Source : ClinicalTrials.gov
|
Zuhair Saleh Natto
|
Contact
Last imported at : June 30, 2021, 2:30 a.m.
Source : ClinicalTrials.gov
|
Not reported
|
Registration date
Last imported at : June 30, 2021, 2:30 a.m.
Source : ClinicalTrials.gov
|
2021-06-28
|
Recruitment status
Last imported at : June 4, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
Unknown
|
Study design
Last imported at : June 30, 2021, 2:30 a.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : June 30, 2021, 2:30 a.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : June 30, 2021, 2:30 a.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : June 30, 2021, 2:30 a.m.
Source : ClinicalTrials.gov
|
Blind label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
single-center
|
Study aim
Last imported at : June 30, 2021, 2:30 a.m.
Source : ClinicalTrials.gov
|
Treatment
|
Inclusion criteria
Last imported at : June 30, 2021, 2:30 a.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
- a history of positive nasal swabs for sars-cov-2 based on reverse-transcription
polymerase chain reaction (rt-pcr) assays.
|
Exclusion criteria
Last imported at : June 30, 2021, 2:30 a.m.
Source : ClinicalTrials.gov
|
- history of allergy to any of the products that will be used
- known pregnancy
- renal failure
|
Number of arms
Last imported at : June 30, 2021, 2:30 a.m.
Source : ClinicalTrials.gov
|
4
|
Funding
Last imported at : June 30, 2021, 2:30 a.m.
Source : ClinicalTrials.gov
|
King Abdulaziz University
|
Inclusion age min
Last imported at : June 30, 2021, 2:30 a.m.
Source : ClinicalTrials.gov
|
21
|
Inclusion age max
Last imported at : June 30, 2021, 2:30 a.m.
Source : ClinicalTrials.gov
|
80
|
Countries
Last imported at : June 30, 2021, 2:30 a.m.
Source : ClinicalTrials.gov
|
Saudi Arabia
|
Type of patients
Last imported at : June 30, 2021, 2:30 a.m.
Source : ClinicalTrials.gov
|
No restriction on type of patients
|
Severity scale
Last imported at : June 30, 2021, 2:30 a.m.
Source : ClinicalTrials.gov
|
0: No restriction on type of patients
|
Total sample size
Last imported at : June 30, 2021, 2:30 a.m.
Source : ClinicalTrials.gov
|
60
|
primary outcome
Last imported at : July 8, 2021, 4 a.m.
Source : ClinicalTrials.gov
|
quantity of the virus in the saliva measured by Q- PCR
|
Notes
Last imported at : June 30, 2021, 2:30 a.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : June 30, 2021, 2:30 a.m.
Source : ClinicalTrials.gov
|
Phase 4
|
Arms
Last imported at : June 30, 2021, 2:30 a.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "", "treatment_id": 1453, "treatment_name": "Chlorhexidine+povidone-iodine", "treatment_type": "Mouthwash", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 275, "treatment_name": "Chlorhexidine lozenges", "treatment_type": "Mouthwash", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 1015, "treatment_name": "Povidone-iodine", "treatment_type": "Mouthwash", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]
|